Finance

Lists
Why is NXTC down 7,85%?
Dive Deeper
NXTC:NASDAQ
NextCure Inc
5,75 USD
-7,85%
(-0,49) 1D
19-окт., 13:19:20 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NXTC...
Open
6,16 USD
High
6,46 USD
Low
5,58 USD
Mkt. cap
26,32 млн
Avg. vol.
92,32 миң
Volume
44,17 миң
52-wk high
15,74 USD
52-wk low
1,55 USD
EPS
-10,27 USD
Beta
1,33
Shares outstanding
4,58 млн
No. of employees
40
Open
6,16 USD
High
6,46 USD
Low
5,58 USD
Mkt. cap
26,32 млн
Avg. vol.
92,32 миң
Volume
44,17 миң
52-wk high
15,74 USD
52-wk low
1,55 USD
EPS
-10,27 USD
Beta
1,33
Shares outstanding
4,58 млн
No. of employees
40
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
4 саат мурун
Technical Reactions to NXTC Trends in Macro Strategies
About NextCure Inc
CEO-
Employees40
Founded2015
Headquarters-
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to NXTC in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for NXTC in the last 3 months
Highest
Current 5,75 USD
20,00 USD (+247,83%)
Average
20,00 USD (+247,83%)
Lowest
20,00 USD (+247,83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
20,00 USD
+247,8%
08/13/2026
Edward Tenthoff
Piper Sandler
Buy
Maintained
15,00 USD
+160,9%
06/10/2026
Christopher Liu
Lucid Capital
Buy
Maintained
25,00 USD
+334,8%
06/02/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Upgraded
18,00 USD
+213%
11/07/2025
Last report
2026-ж., 6-авг.
Fiscal period
Q2 2026
-1,85 USD / -1,92 USD
+3,85%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6,14 млн
6,80 млн
6,83 млн
7,42 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,81 млн
2,96 млн
3,27 млн
2,59 млн
Operating expense
8,94 млн
9,76 млн
10,10 млн
10,02 млн
Total operating expenses
8,94 млн
9,76 млн
10,10 млн
10,02 млн
Operating income
-8,94 млн
-9,76 млн
-10,10 млн
-10,02 млн
Other non operating income
-
-
-
-
EBT including unusual items
-8,62 млн
-9,44 млн
-9,80 млн
-14,89 млн
EBT excluding unusual items
-8,62 млн
-9,44 млн
-9,80 млн
-9,82 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8,62 млн
-9,44 млн
-9,80 млн
-14,89 млн
Net profit margin
-
-
-
-
Earnings per share
-3,22
-0,81
-1,87
-1,85
Interest and investment income
321,00 миң
321,00 миң
309,00 миң
202,00 миң
Interest expense
-
-
-
-
Net interest expenses
321,00 миң
321,00 миң
309,00 миң
202,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-8,41 млн
-9,39 млн
-9,82 млн
-9,74 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору